Imatinib as adjuvant treatment following resection of KIT-positive gastrointestinal stromal tumours

Por J Dretzke, J Round, M Connock, S Tubeuf, M Pennant, A Fry-Smith, C Hulme, C McCabe, C Meads
Publicado em 2010-10-01

A systematic review and economic evaluation of the use of tumour necrosis factor-alpha (TNF-α) inhibitors, adalimumab and infliximab, for Crohn’s disease

Por J Dretzke, R Edlin, J Round, M Connock, C Hulme, J Czeczot, A Fry-Smith, C McCabe, C Meads
Publicado em 2011-02-01

The effectiveness and cost-effectiveness of acupressure for the control and management of chemotherapy-related acute and delayed nausea: Assessment of Nausea in Chemotherapy Resear...

Por A Molassiotis, W Russell, J Hughes, M Breckons, M Lloyd-Williams, J Richardson, C Hulme, S Brearley, M Campbell, A Garrow, WD Ryder
Publicado em 2013-06-01

Simvastatin for patients with acute respiratory distress syndrome: long-term outcomes and cost-effectiveness from a randomised controlled trial

Por A. Agus, C. Hulme, R. M. Verghis, C. McDowell, C. Jackson, C. M. O’Kane, J. G. Laffey, D. F. McAuley
Publicado em 2017-05-01